Park Edge Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Park Edge Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$769K	Sell	12,316 -2,065	-14%	-$131K	0.16%	88
2026 Q2	$829K	Hold	14,381	–	–	0.17%	87
2026 Q1	$872K	Sell	14,381 -19	-0.1%	-$1.11K	0.2%	77
2025 Q4	$777K	Hold	14,400	–	–	0.18%	85
2025 Q3	$649K	Sell	14,400 -377	-3%	-$17.6K	0.15%	86
2025 Q2	$684K	Hold	14,777	–	–	0.18%	83
2025 Q1	$901K	Hold	14,777	–	–	0.25%	71
2024 Q4	$836K	Hold	14,777	–	–	0.24%	69
2024 Q3	$765K	Sell	14,777 -600	-4%	-$28.1K	0.22%	79
2024 Q2	$639K	Sell	15,377 -500	-3%	-$22.4K	0.2%	80
2024 Q1	$861K	Sell	15,877 -826	-5%	-$42.1K	0.24%	59
2023 Q4	$857K	Hold	16,703	–	–	0.3%	46
2023 Q3	$969K	Hold	16,703	–	–	0.35%	32
2023 Q2	$1.07M	Sell	16,703 -598	-3%	-$40.1K	0.36%	26
2023 Q1	$1.2M	Sell	17,301 -210	-1%	-$14.8K	0.46%	22
2022 Q4	$1.26M	Buy	+17,511	New	+$1.32M	0.55%	23

Other funds holding BMY

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return

Park Edge Advisors's BMY Position: Q3 2026 in Review

Park Edge Advisors reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q3 2026, selling an estimated $131K and leaving 12,316 shares worth $769K. The position accounts for 0.16% of the portfolio, ranked #88.

Park Edge Advisors first reported a position in BMY in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.26M in Q4 2022. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Park Edge Advisors held 12,316 shares of Bristol-Myers Squibb worth $769K as of Q3 2026.
Park Edge Advisors sold 2,065 Bristol-Myers Squibb shares in Q3 2026, an estimated $131K.
Bristol-Myers Squibb made up 0.16% of Park Edge Advisors's portfolio in Q3 2026, its #88 holding.
Park Edge Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 16 quarters since.
Park Edge Advisors's Bristol-Myers Squibb position peaked at $1.26M in Q4 2022.
2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Park Edge Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.